Vendor source

Reviewed 17 Jun 2026

Completeness Strong (78%)

QP-Prostate

Quibim

QP-Prostate is a medical imaging software that supports radiologists in the detection of clinically significant prostate cancer. It provides automatic lesion detection and risk scoring (High and Moderate) for the presence of csPCa. It also provides quantitative information, including prostate volume and dimensions, Apparent Diffusion Coefficient (ADC) map, computed high b-value and perfusion metrics (K trans, K ep, V e). The information is compiled by the radiologist in a prostate structured report template based on PI-RADS guidelines.

Supported by 1 paper

QP-Prostate thumbnail 1
QP-Prostate thumbnail 2
QP-Prostate thumbnail 3

Key Features

  • PI-RADS 2.1 structured report
  • Prostate segmentation

General Information

Product name

QP-Prostate

Company

Modality

MR

Main task

Not specified

Subspeciality

Abdomen

Disease targeted

Prostate Cancer

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIb

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

FDA Number:

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

T2w, DWI sequence, DCE (not needed for lesion detection)

Input format

DICOM

Output

Lesion detection overlay, prostate segmentation overlay, quantitative information (ADC, high b-value, Ktrans, Kep, Ve), structured report based on PI-RADS 2.1

Output format

DICOM SC

Integration

Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased

Deployment

Cloud-based

Trigger for analysis

Automatically, right after the image acquisition

Processing time

1 - 10 minutes

Population

Male adult population. Exclusion: patients with endorectal coil, radical prostatectomy or hip prosthesis.

Market Presence

On market since

CE/UKCA 10-2022. 510(k) clearance since 12-2020.

AI Platforms

Resellers

Not specified

Countries present

10

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Number of analyses

Source: Vendor | First published: Jan 30, 2024 | Last updated: Jun 17, 2026

QP-Prostate - Quibim